ESSA Pharma Inc
EPIX
View Detailed Chart
0.201USD
0.0000.00%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
8.93MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
0.00%
6 Months
-89.24%
Year to Date
0.00%
1 Year
-88.16%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
ESSA Pharma Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
ESSA Pharma Inc Info
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, Masofaniten (formerly EPI-7386), is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). Masofaniten is in development in combination with antiandrogen treatments in patients with prostate cancer who are earlier in their course of the disease. The Company is completing the clinical development of masofaniten as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
Ticker SymbolEPIX
CompanyESSA Pharma Inc
CEODr. David Ross Parkinson, M.D.
Websitehttps://www.essapharma.com/
Related Instruments
0.00%
-3.01%
+0.42%
+0.45%
0.00%
+0.50%
+8.57%
+0.48%
0.00%
0.00%
+0.97%
+0.68%
0.00%
+9.08%
+0.44%
-1.39%
-0.09%
+0.86%
-0.29%
0.00%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
69070.010
-900.120 (-1.29%)
282.580
+22.390 (+8.61%)
2057.630
+5.900 (+0.29%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
